Letter: Does Serum <scp>HBV RNA</scp> Add Incremental Value for Hepatocellular Carcinoma Risk Stratification Beyond Established Predictors? Authors' Reply

Takashi Kumada, Hidenori Toyoda, Satoshi Yasuda, Yuichi Koshiyama, Takanori Ito, Tomoyuki Akita, Junko Tanaka

Open source

DOI
10.1111/apt.70730
Published
2026-05-12
Container
Alimentary Pharmacology &amp; Therapeutics
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/apt.70730,
  title = {Letter: Does Serum
                    <scp>HBV RNA</scp>
                    Add Incremental Value for Hepatocellular Carcinoma Risk Stratification Beyond Established Predictors? Authors' Reply},
  author = {Takashi Kumada and Hidenori Toyoda and Satoshi Yasuda and Yuichi Koshiyama and Takanori Ito and Tomoyuki Akita and Junko Tanaka},
  year = {2026},
  journal = {Alimentary Pharmacology \&amp; Therapeutics},
  doi = {10.1111/apt.70730},
  url = {https://doi.org/10.1111/apt.70730}
}

RIS

TY  - JOUR
TI  - Letter: Does Serum
                    <scp>HBV RNA</scp>
                    Add Incremental Value for Hepatocellular Carcinoma Risk Stratification Beyond Established Predictors? Authors' Reply
AU  - Takashi Kumada
AU  - Hidenori Toyoda
AU  - Satoshi Yasuda
AU  - Yuichi Koshiyama
AU  - Takanori Ito
AU  - Tomoyuki Akita
AU  - Junko Tanaka
PY  - 2026
JO  - Alimentary Pharmacology &amp; Therapeutics
DO  - 10.1111/apt.70730
UR  - https://doi.org/10.1111/apt.70730
ER  - 

APA

Kumada, T., Toyoda, H., Yasuda, S., Koshiyama, Y., Ito, T., Akita, T., & Tanaka, J. (2026). Letter: Does Serum <scp>HBV RNA</scp> Add Incremental Value for Hepatocellular Carcinoma Risk Stratification Beyond Established Predictors? Authors' Reply. Alimentary Pharmacology &amp; Therapeutics. https://doi.org/10.1111/apt.70730

Source records